6-Chloro-2-(1-piperazinyl)quinoxaline

CPQ
Clinical data
Other namesCPQ; 4-Aza-7-chloroquipazine
Drug classSelective serotonin reuptake inhibitor (SSRI)
ATC code
  • None
Identifiers
  • 6-chloro-2-piperazin-1-ylquinoxaline
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC12H13ClN4
Molar mass248.71 g·mol−1
3D model (JSmol)
  • C1CN(CCN1)C2=CN=C3C=C(C=CC3=N2)Cl
  • InChI=1S/C12H13ClN4/c13-9-1-2-10-11(7-9)15-8-12(16-10)17-5-3-14-4-6-17/h1-2,7-8,14H,3-6H2
  • Key:PSJNXVYMPJQNGI-UHFFFAOYSA-N

6-Chloro-2-(1-piperazinyl)quinoxaline (CPQ), also known as 4-aza-7-chloroquipazine, is a selective serotonin reuptake inhibitor (SSRI) of the arylpiperazine family related to quipazine.[1] It is highly potent and shows high selectivity for inhibiting the reuptake of serotonin over the reuptake of norepinephrine and dopamine.[1] The drug potentiates the head-twitch response (HTR) and forepaw clonus induced by 5-hydroxytryptophan (5-HTP) and antagonizes para-chloromethamphetamine (PCMA)-induced HTR and serotonergic neurotoxicity, effects which may be attributed to its serotonin reuptake inhibition.[1] The chemical synthesis of CPQ has been described.[2] CPQ was described in the scientific literature in 1978.[1]

See also

References

  1. 1 2 3 4 Lotti VJ, Clineschmidt BV, Haubrich D, Porter CC (September 1978). "6-Chloro-2(1-piperazinyl) quinoxaline (CPQ): action on serotonin-induced behavioral responses and interactions with chloromethamphetamine and dimethyl-meta-tyramine". Archives Internationales de Pharmacodynamie et de Therapie. 235 (1): 103–115. PMID 153735.
  2. ↑ Saari WS, Lumma WC (1978). "Synthesis of some 2,3- 14 C-quinoxaline derivatives". Journal of Labelled Compounds and Radiopharmaceuticals. 14 (3): 349–353. doi:10.1002/jlcr.2580140306. ISSN 0362-4803.